Home › Core › ISCC-IDs › 28CrZ77B92GGV

View ISCC-ID

Core Data

28CrZ77B92GGV
ISCC-ID - digital asset identifier
CChoXUt2JD8Np-CTcyBZHSM8H93-CDWwjGufyeQUn-CRLy1Sqhre6VJ
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

thu0178 long term safety profile of methotrexate in patients with ra in routine care

Ledger Reference

coblo
Source Ledger/Blockchain
438300
N-th ISCC Decleration on source ledger
7e5ee5086df1b5b248167b0be48f925c0f22b0f43d98fbf4b05ef6355667795e
Hash of block that includes the ISCC-DECLARATION
12e0a3cdc64dd8b87d7df2dcab1bbcb593ee1c893ce65fc52543da81b616c0e2
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "THU0178\u2005Long term safety profile of methotrexate in patients with ra in routine care", "@type": "ScholarlyArticle", "genre": "proceedings-article", "author": [{"name": "AB Nalawade", "@type": "Person"}, {"name": "SM Akerkar", "@type": "Person"}, {"name": "BD Pandey", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://ard.bmj.com/content/annrheumdis/76/Suppl_2/269.1.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "BMJ Publishing Group Ltd and European League Against Rheumatism", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1136/annrheumdis-2017-eular.4055", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CChoXUt2JD8Np-CTcyBZHSM8H93-CDWwjGufyeQUn-CRLy1Sqhre6VJ", "propertyID": "ISCC"}], "datePublished": "2017-06-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close